Between 1982 and 2009 a total of 92 patients with myelofibrosis (MF) in chronic phase
underwent allo-SCT in nine Nordic transplant centers. Myeloablative conditioning (MAC) …

BACKGROUND. Survival in primary myelofibrosis (PMF) is predicted by several prognostic
scoring systems (PSSs); the most widely recognized is that of Dupriez. Two other PSSs …

Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
the clinical manifestations of myelofibrosis with myeloid metaplasia and recent …

Allogeneic haematopoietic stem cell transplantation remains the only curative treatment of
myelofibrosis with myeloid metaplasia (MMM). Previous reports have indicated significant …

Hemopoietic cell transplantation (HCT) is presently the only therapy with curative potential
for myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPD). Among …

Idiopathic myelofibrosis (IMF) is a clonal disorder resulting from the proliferation of aberrant
hematopoietic stem cells. Conventional treatment is unsatisfactory, and with the exception of …

Primary myelofibrosis (PMF) is a chronic myeloproliferative neoplasm characterized by
progressive anemia, massive splenomegaly, leukoerythroblastosis, extramedullary …

Scant knowledge exists concerning lineagerestricted mixed chimerism (mCh) after
allogeneic peripheral blood stem cell transplantation (PSCT) in patients with chronic …

Myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPD) are clonal
diseases of hematopoietic precursors/stem cells. While the course may be protracted, these …

Myelofibrosis with myeloid metaplasia is a clonal disorder resulting from proliferation of
aberrant hematopoietic progenitors. It can occur either de novo or secondary to an …